ViroPharma Inc.'s (VPHM) fourth-quarter net income fell to $18 million, or 25 cents a share, from $72.7 million, or $1.17 a share, a year ago, due in part to a change in income tax accounting.
A Thomson Financial survey of analysts, on average, predicted earnings of 20 cents a share for the quarter. Analysts' estimates usually exclude items.
The Exton, Pa., pharmaceutical company's revenue fell 4.6% to $38.6 million from $40.5 million a year ago.
For 2007, the company expects net product sales of $195 million to $205 million.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.